About Nextkidney
WHO WE ARE
Nextkidney is a Dutch company with subsidiaries in Switzerland and Singapore,
co-founded by the Dutch Kidney Foundation and supported by major Dutch health
insurers and patients’ associations and medical professionals worldwide.
WHAT WE DO
Nextkidney has developed the first truly portable Home Hemodialysis device, the Neokidney. It makes dialysis possible wherever and whenever patients want and gives them their autonomy and freedom back.
A number of advantages in a row :
Better quality of life for patients.
Supports frequent dialysis leading to a higher life expectancy.
Lower treatment costs due to less support from healthcare
professionals and less dialysis fluid required.
WHY WE DO IT
We want to use technological innovations to give kidney dialysis patients their lives back, enabling them to adapt the treatment to their lives instead of their lives being dictated by the treatment.
MULTIPLE AWARD-WINNING COMPANY
Built by a team of experienced experts
Jérôme Augustin
Chief Executive Officer
John Stooker
Chief Operating Officer &
Chief Financial Officer
Christian Bluechel
Chief Technological Officer
Christophe Conan
R&D Director
Jasmin Wong
Director, APAC Operations & Global Business Development
Dr Dieter Bach
Chief Medical Officer
Meet our teams
Transparency Reporting of Clinical Trials and Research Activities
At NextKidney, we are committed to conducting clinical research in an ethical, transparent, and compliant manner. Transparency is an essential component of our collaboration with healthcare professionals, healthcare organizations, research institutions, and patients. Our clinical studies are conducted in accordance with applicable laws, regulations, Good Clinical Practice (GCP) where applicable, and relevant industry codes.
We comply with applicable local transparency reporting requirements in the countries where we conduct clinical research and collaborate with healthcare professionals and healthcare organizations. Where national transparency registers or public disclosure systems are available, we report the required information in accordance with local legal and regulatory requirements. Examples may include disclosures relating to clinical trial agreements, research funding, investigator compensation, and other reportable transfers of value.
In countries where no national transparency register or equivalent public reporting platform exists, or where local regulations require company-level disclosure, we publish the relevant information on this website. Such disclosures are made in accordance with applicable laws and industry standards and are intended to provide stakeholders with clear information regarding our interactions and research collaborations.
Through this approach, we seek to promote trust, accountability, and openness in clinical research while supporting innovation that advances patient care.
Published Transparency Reports
Where required and applicable, transparency reports that are not reported through a national transparency register will be made available below :
- Clinical Trial and Research Collaboration Disclosures
- Transfers of Value to Healthcare Professionals (HCPs)
- Transfers of Value to Healthcare Organizations (HCOs)
- Research and Development (R&D) Disclosures
- Historical Transparency Reports
For questions regarding our transparency reporting practices, please contact our manager Jezreel Zaragosa (j.zaragosa@nextkidney.com)